Compounds > levodopa
Page last updated: 2024-08-17

levodopa and Hallervorden-Spatz Disease

levodopa has been researched along with Hallervorden-Spatz Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cossu, G; Floris, G; Hayflick, SJ; Melis, M; Spissu, A1
Ali, SN; Asumal, KB; Wasay, M1
Clement, F; Coubes, P; Defebvre, L; Destee, A; Devos, D; Moreau, C1
Date, ES; Schwartz, M; Seibel, MO; Zeiner, H1
Lang, AE; Provias, JP; Tuite, PJ1
Barkhatova, VP; Insarova, NG; Ivanova-Smolenskaia, IA; Markova, ED1

Other Studies

6 other study(ies) available for levodopa and Hallervorden-Spatz Disease

ArticleYear
Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene.
    Journal of neurology, 2002, Volume: 249, Issue:11

    Topics: Adult; Dibenzothiazepines; Female; Globus Pallidus; Homozygote; Humans; Italy; Levodopa; Magnetic Resonance Imaging; Male; Mutation, Missense; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Quetiapine Fumarate

2002
Radiologic features of Hallervorden Spatz Disease.
    JPMA. The Journal of the Pakistan Medical Association, 2002, Volume: 52, Issue:11

    Topics: Adolescent; Child; Diagnosis, Differential; Humans; Levodopa; Magnetic Resonance Imaging; Male; Pantothenate Kinase-Associated Neurodegeneration

2002
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
    Acta neurologica Belgica, 2007, Volume: 107, Issue:1

    Topics: Adolescent; Brain; Brain Diseases, Metabolic; Diagnosis, Differential; DNA Mutational Analysis; Dystonia; Female; Genetic Predisposition to Disease; Humans; Iron; Iron Metabolism Disorders; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurodegenerative Diseases; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Treatment Outcome

2007
Rehabilitation of patients with Hallervorden-Spatz syndrome.
    Archives of physical medicine and rehabilitation, 1993, Volume: 74, Issue:3

    Topics: Activities of Daily Living; Adult; Carbidopa; Drug Therapy, Combination; Exercise Therapy; Humans; Levodopa; Male; Movement Disorders; Pantothenate Kinase-Associated Neurodegeneration; Patient Care Team

1993
Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease, and some pathological features of Hallervorden-Spatz disease.
    Journal of neurology, neurosurgery, and psychiatry, 1996, Volume: 61, Issue:5

    Topics: Adult; Antiparkinson Agents; Brain; Humans; Hypertrophy; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease; Substantia Nigra

1996
[Clinical picture and treatment of Parkinson-like syndromes of hereditary etiology].
    Klinicheskaia meditsina, 1978, Volume: 56, Issue:9

    Topics: Adolescent; Adult; Basal Ganglia Diseases; Child; Diagnosis, Differential; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease

1978